π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The purpose of this study is to learn how to use blood tests to better pred...
Status
Terminated
Location
Columbia University Irving Medical Center
Start Date
2020-02-01
Trial ID
NCT04791215
Treatments Being Tested
Circulating free cell DNA (cfDNA) is extracellular fragmentation of nucleic...
Status
Unknown
Location
Stanford Genome Technology Center
Start Date
2014-01
Trial ID
NCT02036216
The recent histo-prognostic molecular discoveries of the TCGA (The Cancer G...
Status
Completed
Location
CHU Poitiers, PRC
Start Date
2020-06-19
Trial ID
NCT04456972
Treatments Being Tested
Recently, a number of clinical studies were carried out to evaluate the the...
Status
Unknown
Location
Multiple Locations
Start Date
2022-10
Trial ID
NCT05594381
Treatments Being Tested
Multi-center observational clinical study to evaluate the application value...
Status
Unknown
Location
Parc de Salut Mar - Hospital del Mar
Start Date
2021-02-01
Trial ID
NCT05641870
The study aims to explore the prevalence of ALK/ROS1/MET mutations assessed...
Status
Unknown
Location
Hangzhou First People's Hospital, Nanjing Medical University
Start Date
2016-11
Trial ID
NCT02946216
Treatments Being Tested
Circulating tumor DNA (ctDNA) is a highly specific and effective biomarker ...
Status
Unknown
Location
Pamela Youde Nethersole Eastern Hospital
Start Date
2017-02-24
Trial ID
NCT02811354
Treatments Being Tested
For patients with newly diagnosed or relapsed/metastatic B-cell non-Hodgkin...
Status
Active Not Recruiting
Location
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2026-01-01
Trial ID
NCT07480837
This clinical trial aims to explore the minimal residual disease (MRD) stat...
Status
Unknown
Location
The Second Affiliated The Second Affiliated Hospital of Air Force Medical University (Tangdu Hospital)
Start Date
2021-09-30
Trial ID
NCT05167604
Treatments Being Tested
Activating mutations of the kinases CKIT or PDGFRA can be detected in 90% o...
Status
Completed
Location
Klinikum rechts der Isar - III. Medizinische Klinik und Poliklinik
Start Date
2011-11
Trial ID
NCT01462994